Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

Bálint, Anita, Rutka, Mariann, Végh, Zsuzsanna, Kürti, Zsuzsanna, Gecse, Krisztina Barbara, Lakatos, László, Szepes, Zoltán, Vincze, Áron, Bor, Renáta, Milassin, Ágnes, Fábián, Anna, Nagy, Ferenc, Lakatos, Péter László, Molnár, Tamás, Farkas, Klaudia: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.
EXPERT OPINION ON DRUG SAFETY, 16 (8). pp. 885-890. ISSN 1474-0338 (2017)

[img]
Preview
Text
3225452_Balint_EODS_2017l_u.pdf - Published Version

Download (1MB) | Preview
Item Type: Article
Szerzők száma: 33
Journal or Publication Title: EXPERT OPINION ON DRUG SAFETY
Date: 2017
Volume: 16
Number: 8
Page Range: pp. 885-890
ISSN: 1474-0338
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 3225452
DOI id: https://doi.org/10.1080/14740338.2017.1323330
Date Deposited: 2017. Sep. 29. 12:10
Last Modified: 2019. Oct. 25. 11:32
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12010

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year